1.
Schlesinger T, Kircik L, Armstrong A, Berman B, Bhatia N, Del Rosso J, Lebwohl M, Patel V, Rigel D, Narayanan S, Koscielny V, Kasujee I. Investigator Global assessment (IGA) of Actinic Keratosis (AK) among patients administered tirbanibulin in real-world community practices across the U.S., and clinician likelihood to consider tirbanibulin again for future AK treatments (PROAK Study). J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s162. Available from: https://jofskin.org/33014/index.php/skin/article/view/2048